Dual-Acting Small Molecules: Subtype-Selective Cannabinoid Receptor 2 Agonist/Butyrylcholinesterase Inhibitor Hybrids Show Neuroprotection in an Alzheimer’s Disease Mouse Model-Reference-Cited by-同舟云学术

Dual-Acting Small Molecules: Subtype-Selective Cannabinoid Receptor 2 Agonist/Butyrylcholinesterase Inhibitor Hybrids Show Neuroprotection in an Alzheimer’s Disease Mouse Model

Published:2023-04-26 Issue:9 Volume:66 Page:6414-6435
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Spatz Philipp¹,Steinmüller Sophie A. M.¹^ORCID,Tutov Anna¹^ORCID,Poeta Eleonora²,Morilleau Axelle³,Carles Allison³,Deventer Marie H.⁴,Hofmann Julian¹,Stove Christophe P.⁴^ORCID,Monti Barbara²^ORCID,Maurice Tangui³^ORCID,Decker Michael¹^ORCID

Affiliation:

1. Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy and Food Chemistry, Julius Maximilian University Würzburg, Am Hubland, D-97074 Würzburg, Germany

2. Department of Pharmacy and Biotechnology, University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy

3. MMDN, University of Montpellier, EPHE, INSERM, 34095 Montpellier, France

4. Laboratory of Toxicology, Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460, 9000 Ghent, Belgium

Funder

Elitenetzwerk Bayern

Deutsche Forschungsgemeinschaft

Fonds Wetenschappelijk Onderzoek

Bayerisch-Franz?sisches Hochschulzentrum

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.3c00541

Reference88 articles.